{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:49:08Z","timestamp":1792741748946,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04183-5","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:09:37Z","timestamp":1770365377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-8161","authenticated-orcid":false,"given":"Gast\u00f3n Wilmer","family":"Mendoza De Lama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-1086","authenticated-orcid":false,"given":"Nancy Elena","family":"Mu\u00f1oz Quispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0812-0756","authenticated-orcid":false,"given":"Jorge Marcelo","family":"Aguilar Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-309X","authenticated-orcid":false,"given":"Samantha","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0085-7328","authenticated-orcid":false,"given":"Renson Eduardo","family":"Hidalgo Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5035-9068","authenticated-orcid":false,"given":"Diana","family":"D\u00edaz-Llontop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7018-0205","authenticated-orcid":false,"given":"Richard Eduardo","family":"Castillo Laborio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-6569","authenticated-orcid":false,"given":"Juan Manuel","family":"Trejo Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6792-2371","authenticated-orcid":false,"given":"Enrique Oswaldo","family":"Bedoya Ismodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-9149","authenticated-orcid":false,"given":"Luis","family":"Taxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"4183_CR1","doi-asserted-by":"crossref","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, et al. Breast cancer: pathogenesis and treatments. Vol. 10, Signal Transduction and Targeted Therapy. Springer Nature; 2025. https:\/\/doi.org\/10.1038\/s41392-024-02108-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/39966355\/.","DOI":"10.1038\/s41392-024-02108-4"},{"key":"4183_CR2","doi-asserted-by":"crossref","unstructured":"L\u00f3pez Gordo S, Borisova I, Ruiz-Edo N, L\u00f3pez-Cano D, De la Igl\u00e9sia M, Giner Pichel M, et al. Indocyanine green for axillary sentinel lymph node biopsy in patients with breast cancer (INSEAN study). Cirug\u00eda Espa\u00f1ola (English Edition). 2025;103(3):173-8. https:\/\/doi.org\/10.1016\/j.cireng.2024.11.017. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S2173507725000080?via%3Dihub. Cited 2025 Sep 22.","DOI":"10.1016\/j.cireng.2024.11.017"},{"key":"4183_CR3","doi-asserted-by":"crossref","unstructured":"Somashekhar SP, Kumar CR, Ashwin KR, Zaveri SS, Jampani A, Ramya Y, et al. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study. Clin Breast Cancer. 2020;20(5):e576-83. https:\/\/doi.org\/10.1016\/j.clbc.2020.03.013. https:\/\/pubmed.ncbi.nlm.nih.gov\/32389561\/.","DOI":"10.1016\/j.clbc.2020.03.013"},{"key":"4183_CR4","doi-asserted-by":"crossref","unstructured":"Morales-Conde S, Licardie E, Alarc\u00f3n I, Balla A. Indocyanine green (ICG) fluorescence guide for the use and indications in general surgery: Recommendations based on the descriptive review of the literature and the analysis of experience. Vol. 100, Cirugia Espanola. Asociacion Espanola de Cirujanos; 2022. p. 534\u201354. https:\/\/doi.org\/10.1016\/j.cireng.2022.06.023. https:\/\/pubmed.ncbi.nlm.nih.gov\/35700889\/.","DOI":"10.1016\/j.cireng.2022.06.023"},{"key":"4183_CR5","doi-asserted-by":"publisher","unstructured":"Da Silva S\u00e1 R, Von Ah Rodrigues RF, Bugalho LA, Da Silva SU, Pinto Naz\u00e1rio AC. Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy. PLoS One. 2023;18(10):e0273886. https:\/\/doi.org\/10.1371\/journal.pone.0273886. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0273886. Cited 2025 Oct 16.\u00a0","DOI":"10.1371\/journal.pone.0273886"},{"key":"4183_CR6","unstructured":"Abstract P4\u201302\u201305: Indocyanine green (ICG) fluorescence mapping for sentinel lymph node (SLN) localization in early breast cancer - Universidad de Chile. Available from: https:\/\/www.bibliotecadigital.uchile.cl\/discovery\/fulldisplay?adaptor=Primo%20Central&context=PC&docid=cdi_crossref_primary_10_1158_1538_7445_SABCS19_P4_02_05&facet=creator,exact,%20Provenzano,%20Elena%20&lang=es&mode=advanced&offset=0&query=creator,exact,%20Provenzano,%20Elena%20,AND&tab=Everything&vid=56UDC_INST:56UDC_INST&utm_source=chatgpt.com. Cited 2025 Oct 19."},{"key":"4183_CR7","doi-asserted-by":"crossref","unstructured":"Heidinger M, Weber WP. Axillary Surgery for Breast Cancer in 2024. Vol. 16, Cancers. Multidisciplinary Digital Publishing Institute (MDPI); 2024. https:\/\/doi.org\/10.3390\/cancers16091623. https:\/\/pubmed.ncbi.nlm.nih.gov\/38730576\/.","DOI":"10.3390\/cancers16091623"},{"key":"4183_CR8","doi-asserted-by":"crossref","unstructured":"Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, Van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. European Journal of Surgical Oncology. 2016;42(4):466\u201373. https:\/\/doi.org\/10.1016\/j.ejso.2015.12.007. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26853759\/. Cited 2025 Oct 19.","DOI":"10.1016\/j.ejso.2015.12.007"},{"key":"4183_CR9","doi-asserted-by":"crossref","unstructured":"Cykowska A, Marano L, D\u2019Ignazio A, Marrelli D, Swierblewski M, Jaskiewicz J, et al. New technologies in breast cancer sentinel lymph node biopsy; from the current gold standard to artificial intelligence. Vol. 34, Surgical Oncology. Elsevier Ltd; 2020. pp. 324-35. https:\/\/doi.org\/10.1016\/j.suronc.2020.06.005. https:\/\/pubmed.ncbi.nlm.nih.gov\/32791443\/.","DOI":"10.1016\/j.suronc.2020.06.005"},{"key":"4183_CR10","doi-asserted-by":"crossref","unstructured":"Da Silva S\u00e1 R, Von Ah Rodrigues RF, Bugalho LA, Da Silva SU, Pinto Naz\u00e1rio AC. Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy. PLoS One. 2023;18(10). https:\/\/doi.org\/10.1371\/journal.pone.0273886. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37878619\/. Cited 2025 Oct 20.","DOI":"10.1371\/journal.pone.0273886"},{"key":"4183_CR11","unstructured":"K\u0119dzierawski P, Bocian A, Radowicz-Chil A, Huruk-Kuchinka A, M\u0119\u017cyk R. Subtype of breast cancer influences sentinel lymph node positivity. Arch Med Sci. 2023;19(3):618\u201325. https:\/\/doi.org\/10.5114\/aoms.2019.88595. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10259389\/."},{"key":"4183_CR12","doi-asserted-by":"publisher","unstructured":"Yin R, Ding LY, Wei QZ, Zhou Y, Tang GY, Zhu X. Comparisons of ICG-fluorescence with conventional tracers in sentinel lymph node biopsy for patients with early-stage breast cancer: A meta-analysis. Oncol Lett. 2021;21(2):1\u20131.\u00a0https:\/\/doi.org\/10.3892\/ol.2020.12375. Available from: http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.12375\/abstract. Cited 2025 Sep 22.","DOI":"10.3892\/ol.2020.12375"},{"key":"4183_CR13","doi-asserted-by":"crossref","unstructured":"Guo J, Yang H, Wang S, Cao Y, Liu M, Xie F, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol. 2017;15(1). https:\/\/doi.org\/10.1186\/s12957-017-1264-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/29096643\/.","DOI":"10.1186\/s12957-017-1264-7"},{"key":"4183_CR14","doi-asserted-by":"crossref","unstructured":"Coibion M, Olivier F, Courtois A, Maes N, Jossa V, Jerusalem G. A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer. Cancers 2022, Vol 14, Page 888 https:\/\/doi.org\/10.3390\/cancers14040888. 2022;14(4):888. Available from: https:\/\/www.mdpi.com\/2072-6694\/14\/4\/888\/htm. Cited 2025 Sep 22.","DOI":"10.3390\/cancers14040888"},{"key":"4183_CR15","doi-asserted-by":"crossref","unstructured":"Bargon CA, Huibers A, Young-Afat DA, Jansen BAM, Borel-Rinkes IHM, Lavalaye J, et al. Sentinel lymph node mapping in breast cancer patients through fluorescent imaging using indocyanine green the influence trial. Ann Surg. 2022;276(5):913\u201320. https:\/\/doi.org\/10.1097\/SLA.0000000000005633. Available from: https:\/\/journals.lww.com\/annalsofsurgery\/fulltext\/2022\/11000\/sentinel_lymph_node_mapping_in_breast_cancer.24.aspx. Cited 2025 Sep 22.","DOI":"10.1097\/SLA.0000000000005633"},{"issue":"13","key":"4183_CR16","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1245\/s10434-024-16176-x","volume":"31","author":"V Pitsinis","year":"2024","unstructured":"Pitsinis V, Kanitkar R, Vinci A, Choong WL, Benson J. <article-title update=\"added\">Results of a prospective randomized multicenter study comparing indocyanine green (ICG) fluorescence combined with a standard tracer versus ICG alone for sentinel lymph node biopsy in early breast cancer: the INFLUENCE trial. Ann Surg Oncol. 2024;31(13):8848\u201355. https:\/\/doi.org\/10.1245\/s10434-024-16176-x.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4183_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4274\/ejbh.galenos.2021.2021-4-11","volume":"17","author":"S Hidar","year":"2021","unstructured":"Hidar S, Alimi A, Khlifi A, Chachia S, Kaabia O, Bouguizane S, et al. Indocyanine green fluorescence-guided sentinel node biopsy in breast cancer within a North African population: a retrospective study. Eur J Breast Health. 2021;17(4):352\u20135. https:\/\/doi.org\/10.4274\/ejbh.galenos.2021.2021-4-11.","journal-title":"Eur J Breast Health"},{"key":"4183_CR18","doi-asserted-by":"publisher","unstructured":"Pinelli M, Gerardi C, Lettieri E, Maioru M, Marone L, Bertoldi L, et al. Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: a multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact. PLoS One. 2024;19(8 August). https:\/\/doi.org\/10.1371\/journal.pone.0309336.","DOI":"10.1371\/journal.pone.0309336"},{"key":"4183_CR19","doi-asserted-by":"publisher","unstructured":"Wang Z, Yang X, Wang J, Liu P, Pan Y, Han C, et al. Real-Time In Situ Navigation System With Indocyanine Green Fluorescence for Sentinel Lymph Node Biopsy in Patients With Breast Cancer. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.621914.","DOI":"10.3389\/fonc.2021.621914"},{"issue":"8","key":"4183_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ejso.2012.05.007","volume":"38","author":"GC Wishart","year":"2012","unstructured":"Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol. 2012;38(8):651\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2012.05.007.","journal-title":"Eur J Surg Oncol"},{"key":"4183_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.31557\/APJCP.2020.21.5.1187","volume":"21","author":"S Thongvitokomarn","year":"2020","unstructured":"Thongvitokomarn S, Polchai N. Indocyanine green fluorescence versus blue dye or radioisotope regarding detection rate of sentinel lymph node biopsy and nodes removed in breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2020;21:1187\u201395. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1187.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4183_CR22","doi-asserted-by":"publisher","unstructured":"Shiller SM, Weir R, Pippen J, Punar M, Savino D. The Sensitivity and Specificity of Sentinel Lymph Node Biopsy for Breast Cancer at Baylor University Medical Center at Dallas: A Retrospective Review of 488 Cases. Baylor Univ Med Center Proc. 2011;24(2):81\u20135. https:\/\/doi.org\/10.1080\/08998280.2011.11928687. Available from: https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08998280.2011.11928687. Cited 2025 Sep 22.\u00a0","DOI":"10.1080\/08998280.2011.11928687"},{"issue":"11","key":"4183_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.4103\/njcp.njcp_154_22","volume":"25","author":"CL Okoye","year":"2022","unstructured":"Okoye CL, Ezeome ER. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria. Niger J Clin Pract. 2022;25(11):1805\u201311. https:\/\/doi.org\/10.4103\/njcp.njcp_154_22.","journal-title":"Niger J Clin Pract"},{"key":"4183_CR24","unstructured":"Marof A, Muhammad Amjad N, Julaihi R, Hardin M, Mushtaq S. The sensitivity and specificity of methylene blue dye as a single agent in sentinel lymph node biopsy for early breast cancer. https:\/\/www.e-mjm.org\/2022\/v77n5\/breast-cancer.pdf."},{"key":"4183_CR25","doi-asserted-by":"crossref","unstructured":"Puthangot A, Chintamani C, Tandon M, Puthangot A, Chintamani C, Tandon M. Evaluation of Axilla With Sentinel Lymph Node Biopsy (Using Methylene-Blue) and Reverse Axillary Mapping (Using Fluorescein) to Validate Optimum and Safe Axillary Dissection in Breast Cancer. Cureus. 2023;15(9). https:\/\/doi.org\/10.7759\/cureus.45267. Available from: https:\/\/cureus.com\/articles\/183523-evaluation-of-axilla-with-sentinel-lymph-node-biopsy-using-methylene-blue-and-reverse-axillary-mapping-using-fluorescein-to-validate-optimum-and-safe-axillary-dissection-in-breast-cancer. Cited 2025 Sep 22.","DOI":"10.7759\/cureus.45267"},{"key":"4183_CR26","unstructured":"Akbari ME, Akbari A, Ebrahimian S. Pathological characteristics predicting sentinel lymph node metastasis in early breast cancer patients. Caspian J Intern Med. 2024;15(3):472\u20137. https:\/\/doi.org\/10.22088\/cjim.15.3.472. Available from: https:\/\/caspjim.com\/article-1-3925-en.html. Cited 2025 Sep 22."},{"key":"4183_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/BCTT.S373005","volume":"14","author":"TS Alsumai","year":"2022","unstructured":"Alsumai TS, Alhazzaa N, Alshamrani A, Assiri S, Alhefdhi A. Factors predicting positive sentinel lymph node biopsy in clinically node-negative breast cancer. Breast Cancer Targets Ther. 2022;14:323\u201334. https:\/\/doi.org\/10.2147\/BCTT.S373005.","journal-title":"Breast Cancer Targets Ther"},{"key":"4183_CR28","doi-asserted-by":"crossref","unstructured":"Abdulla HA, Salman AZ, Alaraibi SJ, Nazzal K, Ahmed SA, Almahari SA, et al. Risk Factors Associated With Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer. Eur J Breast Health. 2023;19(3):229\u201334. https:\/\/doi.org\/10.4274\/ejbh.galenos.2023.2023-3-5. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37415656\/. Cited 2025 Sep 22.","DOI":"10.4274\/ejbh.galenos.2023.2023-3-5"},{"key":"4183_CR29","doi-asserted-by":"crossref","unstructured":"Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, et al. Factors predicting the sentinel and nonsentinel lymph node metastases in breast cancer. Breast Cancer Res Treat. 2006;95(1):1-6. https:\/\/doi.org\/10.1007\/s10549-005-9007-9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16322900\/. Cited 2025 Oct 19.","DOI":"10.1007\/s10549-005-9007-9"},{"key":"4183_CR30","doi-asserted-by":"crossref","unstructured":"Ceylan C, Pehlevan Ozel H, Agackiran I, Altun Ozdemir B, Atas H, Menekse E. Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms. Medicine (United States). 2022;101(48):E32170. https:\/\/doi.org\/10.1097\/MD.0000000000032170. Available from: https:\/\/journals.lww.com\/md-journal\/fulltext\/2022\/12020\/preoperative_predictive_factors_affecting_sentinel.99.aspx. Cited 2025 Oct 20.","DOI":"10.1097\/MD.0000000000032170"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04183-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:07:41Z","timestamp":1773061661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04183-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study involved no direct interaction with the participants. Ethical approval was obtained from the\u202fComit\u00e9\u202fInstitucional\u202fde\u202fBio\u00e9tica\u202fde V\u00eda Libre\u202f(Protocol DETECTA-00001\u20132025, approval period August 12, 2025, to August 11, 2026). The committee granted an exemption from informed consent because the research used retrospective, fully anonymized clinical\u202fdata, ensuring participant privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the final version of this manuscript and consent to its submission and publication in this journal. The authors confirm that the work is original and has not been published elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}